Skip to main content
      EULAR 2024 Highlights: Saturday’s Recap with RheumNow https://t.co/BlOsbr9lYB

      Dr. John Cush RheumNow

      6 months ago
      EULAR 2024 Highlights: Saturday’s Recap with RheumNow https://t.co/BlOsbr9lYB
      #EULARBEST
      RCT of #upadacitinib in #GCA

      It works to steroid spare
      15 mg > 7.5 mg in outcomes
      Both >>placebo

      Janet Pope Janetbirdope

      6 months ago
      #EULARBEST RCT of #upadacitinib in #GCA It works to steroid spare 15 mg > 7.5 mg in outcomes Both >>placebo Ethically PBO had slower #prednisone taper Similar to #TCZ data What to choose in GCA IL6i IL17i JAKi @eular_org @RheumNow LBA0001 https://t.co/gy0TEiHxjo
      Does B Cell Depletion Matter?

      Dr. Yuz Yusof interviews Dr. Ed Vital regarding abstract OP0077 at Eular 2024 in Vienna,

      Dr. John Cush RheumNow

      6 months ago
      Does B Cell Depletion Matter? Dr. Yuz Yusof interviews Dr. Ed Vital regarding abstract OP0077 at Eular 2024 in Vienna, Austria. https://t.co/IjxGWWjoGD https://t.co/GwLjB4Z7ub
      Telespa - telemonitoring in AxSpA « minimal impact on disease control « never examine a patient again , never find a

      Peter Nash drpnash

      6 months ago
      Telespa - telemonitoring in AxSpA « minimal impact on disease control « never examine a patient again , never find any pathology outside of joints, remote SpAologists, no longer physicians - easy to train rheumatology nurses to do our jobs @RheumNow #EULAR2025
      #Scleroderma #recommendations
      #Rayanud’s
      #vasculopathy
      #digital #ulcers

      CCB
      PDE5i
      IV iloprost

      Bosentan for Digital

      Janet Pope Janetbirdope

      6 months ago
      #Scleroderma #recommendations #Rayanud’s #vasculopathy #digital #ulcers CCB PDE5i IV iloprost Bosentan for Digital ulcer prevention <not approved in NA> #EULAR2024 @EUSTAR_org @RheumNow #SSc https://t.co/9c2cHAptIC
      SHR032 chinese JAK1 inhib AS and PsA - typical efficacy and safety - looks like smells like tastes like JAK1 inhib but n

      Peter Nash drpnash

      6 months ago
      SHR032 chinese JAK1 inhib AS and PsA - typical efficacy and safety - looks like smells like tastes like JAK1 inhib but no zoster listed or acne, or anaemia with higher dose, 1 mace 1 vte @RheumNow #EULAR2024
      Duo IL17A,F #SONELOKIMAB
      RCT in active #PsA
      ACR50 around 46%

      Nanobody

      to me it looks like #Bimekizumab results
      So far

      Janet Pope Janetbirdope

      6 months ago
      Duo IL17A,F #SONELOKIMAB RCT in active #PsA ACR50 around 46% Nanobody to me it looks like #Bimekizumab results So far low #fungal infections OP0195 We are over run with + IL17i RCTs in #psoriatic #arthritis Impt~market /access/risk/benefit? #EULAR2024 @eular_org @RheumNow
      Ixokibep a small IL17Ai works in #PsA
      16 wks ▶️50% had PASI 100

      Fast
      40-42% ACR50
      Same rate of MDA
      Helped enthes

      Janet Pope Janetbirdope

      6 months ago
      Ixokibep a small IL17Ai works in #PsA 16 wks ▶️50% had PASI 100 Fast 40-42% ACR50 Same rate of MDA Helped enthesitis also ⬆️injection site rx’n Wow! But where to use vs 2 other IL17Ai and IL17AEi LB0005 #EULAR24 @eular_org @RheumNow
      The electronic nose, knows?

      Exhaled breath volatile organic compounds do surprisingly well in diagnosing RA. Really…

      David Liew drdavidliew

      6 months ago
      The electronic nose, knows? Exhaled breath volatile organic compounds do surprisingly well in diagnosing RA. Really… takes your breath away (as seen in @rheuma_doktorin’s highlights) #EULAR2024 POS0652 @RheumNow https://t.co/OCRHdZZS3Q
      Periodontal disease is a major factor in the development of RA - and that’s the tooth!

      in ACPA+ clinically suspect ar

      David Liew drdavidliew

      6 months ago
      Periodontal disease is a major factor in the development of RA - and that’s the tooth! in ACPA+ clinically suspect arthralgias, tooth extraction: adjusted HR 3.10 Population-level dental care? (as seen in @rheuma_doktorin’s highlights) #EULAR2024 POS0467 @RheumNow https://t.co/wN8bvBtv40
      The MRI SIJ findings in postpartum patients with buttock/pelvic pain remain stable in a 7 year follow up study. They ra

      Dr. Antoni Chan synovialjoints

      6 months ago
      The MRI SIJ findings in postpartum patients with buttock/pelvic pain remain stable in a 7 year follow up study. They rarely develop classical MRI features of axial SpA (i.e. erosion, fat > 1 cm in depth, backfill and ankylosis) or are diagnosed as axial SpA within an 8-year… https://t.co/8M0FP65KPS https://t.co/k1ruzjC7Zy
      Four phenotypes of chronic back pain suspicious of axial spondyloarthritis (axSpA) in the SPACE cohort. These groups wer

      Dr. Antoni Chan synovialjoints

      6 months ago
      Four phenotypes of chronic back pain suspicious of axial spondyloarthritis (axSpA) in the SPACE cohort. These groups were: They were “axial”, “axSpA with peripheral signs”, “at risk” and “no SpA”. Over a 2 year follow up, Transitions between the four classes over two years were… https://t.co/lF1wtAo46Q https://t.co/BXj1nw0tto
      PMR patients get too much steroid.

      Data across 27 million people in England, n=39,438 with PMR.
      The blue are getting mo

      David Liew drdavidliew

      6 months ago
      PMR patients get too much steroid. Data across 27 million people in England, n=39,438 with PMR. The blue are getting more pred than guidelines. Like everything in rheum: we need to be giving less pred, not more. Lumping PMR in with GCA won’t help. #EULAR2024 POS0411 @RheumNow https://t.co/bsi3lrAafm
      ×